As of 2025-04-18, the Relative Valuation of Terns Pharmaceuticals Inc (TERN) is (18.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.40 USD, the upside of Terns Pharmaceuticals Inc based on Relative Valuation is -857.0%.
The range of the Relative Valuation is (15.23) - (19.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 22.9x | 18.8x |
| Forward P/E multiples | 14.6x - 19.5x | 17.0x |
| Fair Price | (15.23) - (19.87) | (18.17) |
| Upside | -734.4% - -927.8% | -857.0% |
| Date | P/E |
| 2025-04-02 | -2.45 |
| 2025-04-01 | -2.52 |
| 2025-03-31 | -2.71 |
| 2025-03-28 | -2.87 |
| 2025-03-27 | -3.07 |
| 2025-03-26 | -3.05 |
| 2025-03-25 | -3.26 |
| 2025-03-24 | -3.45 |
| 2025-03-21 | -3.29 |
| 2025-03-20 | -3.09 |
| 2025-03-19 | -3.10 |
| 2025-03-18 | -3.10 |
| 2025-03-17 | -3.19 |
| 2025-03-14 | -3.12 |
| 2025-03-13 | -3.39 |
| 2025-03-12 | -3.60 |
| 2025-03-11 | -3.42 |
| 2025-03-10 | -3.30 |
| 2025-03-07 | -3.43 |
| 2025-03-06 | -3.57 |
| 2025-03-05 | -3.57 |
| 2025-03-04 | -3.45 |
| 2025-03-03 | -3.33 |
| 2025-02-28 | -3.63 |
| 2025-02-27 | -3.63 |
| 2025-02-26 | -3.69 |
| 2025-02-25 | -3.65 |
| 2025-02-24 | -3.66 |
| 2025-02-21 | -3.93 |
| 2025-02-20 | -4.06 |
| 2025-02-19 | -4.12 |
| 2025-02-18 | -4.06 |
| 2025-02-14 | -3.99 |
| 2025-02-13 | -4.01 |
| 2025-02-12 | -4.26 |
| 2025-02-11 | -4.22 |
| 2025-02-10 | -4.38 |
| 2025-02-07 | -4.40 |
| 2025-02-06 | -4.58 |
| 2025-02-05 | -4.58 |
| 2025-02-04 | -4.44 |
| 2025-02-03 | -4.29 |
| 2025-01-31 | -4.38 |
| 2025-01-30 | -4.56 |
| 2025-01-29 | -4.11 |
| 2025-01-28 | -4.38 |
| 2025-01-27 | -4.45 |
| 2025-01-24 | -4.42 |
| 2025-01-23 | -4.56 |
| 2025-01-22 | -4.59 |